Press Release Database

Contact Levi & Korsinsky by August 28, 2026 to Join Class Action Against ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 21, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hub Group, Inc. (NASDAQ:HUBG) securities. If you suffered a loss on your Hub Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Hub Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..

Announcement of drawings (CK95) - Nykredit Realkredit A/S

To Nasdaq Copenhagen

Announcement of drawings (CK95) - Totalkredit A/S

To Nasdaq Copenhagen

Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S

Til Nasdaq Copenhagen

Udtrækningsmeddelelse (CK95) - Totalkredit A/S

Til Nasdaq Copenhagen

Telestroke Market Strengthens Through Cloud-Based Healthcare Infrastructure

The Telestroke Market is entering a period of rapid expansion as rising stroke incidence, neurologist shortages, and unequal access to specialized care increase the need for remote [read full press release...]

Foresight Evaluates Expansion into New Technology Markets, Including AI-Based Technologies, Cybersecurity and Data Centers

Company explores additional growth opportunities, including the possible acquisition of AI-Based Technologies, Cybersecurity or Data Centers, while continuing its existing business activities

The Metals Royalty Company Announces Fully Allocated US$165 Million ...

(PR-inside.com) US$140 Million Secured Convertible Note Offering and a US$25 Million Senior Secured Term Loan to Fund the Additional Royalty and Repay Existing Indebtedness LONDON, UK / ACCESS Newswire / August 21, 2026 / The Metals Royalty Company Inc. ("TMCR" or the "Company") (Nasdaq:TMCR), today announced a financing package comprised of a US$140 million offering of convertible secured notes (the "Notes") and a US$25 million senior secured term loan facility (the "Loan Facility"). The proceeds of the Notes and the Loan Facility will be used: (i) to fund the closing of the Company's previously announced acquisition of an additional 1.0% Index-Priced Gross Overriding ..

Aehr Test Systems to Participate in the Jefferies Semiconductor, IT ...

(PR-inside.com) FREMONT, CA / ACCESS Newswire / August 21, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced that it will participate in the Jefferies semiconductor, IT Hardware & Communications Technology Conference taking place August 24-25, 2026, at the Four Seasons Hotel in Chicago. President and CEO Gayn Erickson and CFO Chris Siu will be hosting meetings with investors throughout the day on Tuesday, August 25. "We look forward to discussing with investors and shareholders Aehr's expanding role in ..

BULGOLD Announces Filing Of Financial Results For the Six Months Ended ...

(PR-inside.com) TORONTO, ON / ACCESS Newswire / August 21, 2026 /BULGOLD Inc. (TSXV:ZLTO) (the "Company" or "BULGOLD") is pleased to announce that it has filed its unaudited condensed interim financial statements and MD&A for the six months ending June 30, 2026, the company incurred a net loss of $256,437 ($0.00 per share) during the period. On June 30, 2026, the company had cash (and cash equivalents) of $817,147. About BULGOLD Inc. BULGOLD is a gold exploration company focused on the exploration and development of mineral exploration projects in Central and Eastern Europe. The Company controls 100% of three quality quartz-adularia epithermal gold projects ..

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

WARMINSTER, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans to commence a modified “Dutch Auction” tender offer (the “Offer”) to repurchase up to US$230 million of its common shares at a purchase price of not less than US$5.00 per share and not more than US$5.75 per share, in cash, less any applicable withholding taxes and without interest. The Offer is expected to commence on or about August 24, 2026 and, unless extended or terminated by the Company, expire on or about September 29, 2026. The Offer is expected to be funded through the Company’s cash on hand.

Auction result of Treasury Bonds - RIKB 38 0215 - RIKS 29 0917